SciVision Biotech Inc.
A professional hyaluronic acid high-end medical device R&D and production company.
Last updated September 1, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
SciVision Biotech Inc. is a company established in 2001, specializing in the research, development, and production of high-end medical devices made from hyaluronic acid. The company offers products in four major areas: subcutaneous fillers for aesthetic medicine, anti-adhesion gels for surgical use, bladder irrigation solutions for treating cystitis, and more.
History
SciVision Biotech Inc. was established in 2001 as a professional hyaluronic acid high-end medical device R&D and production company. The company has achieved several milestones, including obtaining Taiwan patents for methods of manufacturing cross-linked hyaluronic acid gels and self-cross-linked hyaluronic acid gels, and launching polycaprolactone (PCL) and polylactic acid (PLLA) subcutaneous implants in 2024. In 2026, its hyaluronic acid subcutaneous filler passed EU MDR certification.
Sources1 sources
Cite this profile: Cite the canonical profile. /brand-wiki/scivision-biotech-inc-taiwan · Editorial policy · How profiles are compiled